BS
Insider
Brian Taylor Slingsby
DirectorBrian Taylor Slingsby (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Mineralys Therapeutics, Inc. (MLYS). The largest single filing was $43.4M of MLYS (1,000,000 sh × $43.35, as filed), executed Nov 20 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$43.4M
shares × price, as filed
Last traded
Nov 20 2025
Filed Nov 21 2025
Median ADV $38.0M across their filed names
Open performance→Volume by month
Buys $3.5M
Sells $43.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
MLYS
Mineralys Therapeutics, Inc.
MLYS · 1 buy · 1 sell
2 filings
Recent filings
MLYSSALE
Mineralys Therapeutics, Inc.
View filing →
$43.4M1,000,000 sh × $43.35
Exec Nov 20 2025
Filed Nov 21 2025 · 5:30 PM ET MLYSPURCHASE Mineralys Therapeutics, Inc. View filing → $3.5M
259,259 sh × $13.50
Exec Mar 13 2025
Filed Apr 25 2025 · 5:30 PM ET †